Mallinckrodt, Endo to combine in $7B deal
The merger will give the combined entity the financial flexibility to pursue drug licensing deals and broaden its therapeutic focus, executives said on a conference call.
Hosted on MSN7mon
Three reasons cited by journalist as Liverpool block €14m Wataru Endo transfer and second star holds talks over positional change
Endo himself has admitted the writing may be ... with respected journalist James Pearce revealing they were quick to block the offer for three reasons. Firstly, the timing of the offer did not ...